Analyst Summary: Safeguard Scientifics, Inc. has announced its Q4 and year end 2022 financial results. The Company is continuing to support its companies, but due to the deteriorating business environment, it is considering additional actions to participate in financing transactions. It is also evaluating strategic transactions that could yield greater value to its shareholders. The Company is pursuing a focused strategy to value-maximize and monetize its ownership interests over a multi-year time frame to drive shareholder value. Its CEO, Eric C. Salzman, said, “we remain committed to seeking a path that maximizes shareholder value." Safeguard Scientifics has a distinguished track record of fostering innovation and building market leaders that spans over six decades. However, its forward-looking statements are subject to uncertainties and risks, and it does not guarantee future operational or financial performance.